Methylprednisolone Withdrawn Phase 2 Trials for Anaplastic Large-Cell Lymphoma / Adult Non-Hodgkin's Lymphoma / Lymphoma, AIDS Related / Anaplastic Large Cell Lymphoma Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00310128Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma